In PK/PD studies, the irreversible binding of SY-1530 to BTK was detected in peripheral blood mononuclear cells, thus indicating that SY-1530 suppresses tumor growth through inhibiting BTK (Figure 6B). The gene discussed is BTK; the disease is neoplasm.